J. Söderholm

发表

Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production

J. Bode, M. Sällberg, L. Frelin, 2011, Gut.

Heterologous T Cells Can Help Restore Function in Dysfunctional Hepatitis C Virus Nonstructural 3/4A-Specific T Cells during Therapeutic Vaccination

M. Sällberg, F. Holmström, L. Frelin, 2011, The Journal of Immunology.

In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells1

M. Fons, P. Blomberg, T. Tjelle, 2007, The Journal of Immunology.

Coexpressed RIG-I Agonist Enhances Humoral Immune Response to Influenza Virus DNA Vaccine

J. August, M. Gale, James A. Williams, 2010, Journal of Virology.

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

J. Aurelius, A. Martner, K. Hellstrand, 2010, Expert review of hematology.

High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder

O. Weiland, A. Duberg, S. Larsson, 2020, Scandinavian journal of gastroenterology.

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.

A. Bruchfeld, K. Lindahl, R. Schvarcz, 2017, Journal of hepatology.

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo

P. Liljeström, M. Sällberg, L. Frelin, 2003, Gene Therapy.

Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus

A. Duberg, J. Söderholm, S. Aleman, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

M. Prausnitz, M. Sällberg, H. Gill, 2010, Gene Therapy.

Relation between viral fitness and immune escape within the hepatitis C virus protease

R. Bartenschlager, O. Weiland, P. Liljeström, 2005, Gut.

Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms

A. Neumann, J. Pawlotsky, F. Negro, 2011, PloS one.

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study

M. Gisslén, M. Sällberg, A. Svenningsson, 2019, Journal of Neurology.

Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.

N. Sardesai, A. Bello, G. Kobinger, 2012, Vaccine.

Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease.

W. Hall, M. Sällberg, L. Frelin, 2012, The Journal of general virology.

Limited effect on NS 3 – NS 4 A protein cleavage after alanine substitutions within the immunodominant HLA-A 2-restricted epitope of the hepatitis C virus genotype 3 a non-structural 3 / 4 A protease

W. Hall, M. Sällberg, L. Frelin, 2012 .

A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: relation to recognition by cytotoxic T lymphocytes.

M. Sällberg, J. Söderholm, 2006 .

Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway

J. Damås, R. Hannula, S. Nordbø, 2021, Therapeutic advances in infectious disease.

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens

J. Waring, D. Cohen, A. Vasanthakumar, 2018, PloS one.

Cost-effectiveness of palivizumab in infants with congenital heart disease: a Swedish perspective

E. Fernlund, J. Sunnegårdh, E. Naumburg, 2020, Journal of Congenital Cardiology.

Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study

J. Westin, M. Sällberg, J. Söderholm, 2020, BMJ Open.

Systemic and intrahepatic interferon‐gamma‐inducible protein 10 kDa predicts the first‐phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

A. Neumann, J. Pawlotsky, P. Pugnale, 2010, Hepatology.

Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection

A. Neumann, J. Pawlotsky, F. Negro, 2013, PloS one.

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1

G. Norkrans, K. Hellstrand, J. Westin, 2011, Journal of viral hepatitis.

Response prediction in chronic hepatitis C by assessment of IP-10 and IL 28 B-related single nucleotide polymorphisms LAGGING

A. Neumann, F. Negro, S. Zeuzem, 2017 .

T + Inflammation, and Infiltration of CD3 DNA Uptake, Protein Expression, Nonstructural 3/4A DNA by Increased Local Immunogenicity of Hepatitis C Virus In Vivo Electroporation Enhances the

M. Fons, T. Tjelle, P. Blomberg, 2007 .

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden

O. Weiland, A. Duberg, J. Söderholm, 2017, Scandinavian journal of gastroenterology.